世界のバイオ医薬品経口ドラッグデリバリー市場インサイト及び予測(~2026年)

【英語タイトル】Global Biopharmaceutical Oral Drug Delivery Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV03256)・商品コード:QYR20NV03256
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:114
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはバイオ医薬品経口ドラッグデリバリーの世界市場について調査・分析した資料です。種類別(通常タンパク質(抗体)、核酸(DNA、RNA、オリゴヌクレオチド))の市場規模、用途別(病院薬局、小売薬局、専門薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別バイオ医薬品経口ドラッグデリバリーの競争状況、市場シェア
・世界のバイオ医薬品経口ドラッグデリバリー市場:種類別市場規模 2015年-2020年(通常タンパク質(抗体)、核酸(DNA、RNA、オリゴヌクレオチド))
・世界のバイオ医薬品経口ドラッグデリバリー市場:種類別市場規模予測 2021年-2026年(通常タンパク質(抗体)、核酸(DNA、RNA、オリゴヌクレオチド))
・世界のバイオ医薬品経口ドラッグデリバリー市場:用途別市場規模 2015年-2020年(病院薬局、小売薬局、専門薬局)
・世界のバイオ医薬品経口ドラッグデリバリー市場:用途別市場規模予測 2021年-2026年(病院薬局、小売薬局、専門薬局)
・北米のバイオ医薬品経口ドラッグデリバリー市場分析:米国、カナダ
・ヨーロッパのバイオ医薬品経口ドラッグデリバリー市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバイオ医薬品経口ドラッグデリバリー市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバイオ医薬品経口ドラッグデリバリー市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバイオ医薬品経口ドラッグデリバリー市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie、Amgen、Catalent、Kemwell Bipharma.、Pfizer、Novartis、Biocon、Sanofi、F. Hoffman-La Roche、Novo Nordisk
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Biopharmaceutical Oral Drug Delivery Market
The global Biopharmaceutical Oral Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Biopharmaceutical Oral Drug Delivery Scope and Market Size
Biopharmaceutical Oral Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Oral Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biopharmaceutical Oral Drug Delivery market is segmented into
Normally Protein (Antibodies)
Nucleic Acids (DNA, RNA Or Oligonucleotides)

Segment by Application, the Biopharmaceutical Oral Drug Delivery market is segmented into
Hospital Pharmacy
Retail Pharmacy
Specialty Pharmacy

Regional and Country-level Analysis
The Biopharmaceutical Oral Drug Delivery market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biopharmaceutical Oral Drug Delivery market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biopharmaceutical Oral Drug Delivery Market Share Analysis
Biopharmaceutical Oral Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biopharmaceutical Oral Drug Delivery business, the date to enter into the Biopharmaceutical Oral Drug Delivery market, Biopharmaceutical Oral Drug Delivery product introduction, recent developments, etc.

The major vendors covered:
AbbVie
Amgen
Catalent
Kemwell Bipharma.
Pfizer
Novartis
Biocon
Sanofi
F. Hoffman-La Roche
Novo Nordisk

【レポートの目次】

1 Study Coverage
1.1 Biopharmaceutical Oral Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key Biopharmaceutical Oral Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Type
1.4.2 Normally Protein (Antibodies)
1.4.3 Nucleic Acids (DNA, RNA Or Oligonucleotides)
1.5 Market by Application
1.5.1 Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Specialty Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biopharmaceutical Oral Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global Biopharmaceutical Oral Drug Delivery Revenue 2015-2026
2.1.2 Global Biopharmaceutical Oral Drug Delivery Sales 2015-2026
2.2 Global Biopharmaceutical Oral Drug Delivery, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biopharmaceutical Oral Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biopharmaceutical Oral Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biopharmaceutical Oral Drug Delivery Competitor Landscape by Players
3.1 Biopharmaceutical Oral Drug Delivery Sales by Manufacturers
3.1.1 Biopharmaceutical Oral Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Biopharmaceutical Oral Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers
3.2.1 Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Biopharmaceutical Oral Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biopharmaceutical Oral Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biopharmaceutical Oral Drug Delivery Revenue in 2019
3.2.5 Global Biopharmaceutical Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biopharmaceutical Oral Drug Delivery Price by Manufacturers
3.4 Biopharmaceutical Oral Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Biopharmaceutical Oral Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biopharmaceutical Oral Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Biopharmaceutical Oral Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biopharmaceutical Oral Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020)
4.1.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2015-2020)
4.1.3 Biopharmaceutical Oral Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biopharmaceutical Oral Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Biopharmaceutical Oral Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biopharmaceutical Oral Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Biopharmaceutical Oral Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020)
5.1.2 Global Biopharmaceutical Oral Drug Delivery Revenue by Application (2015-2020)
5.1.3 Biopharmaceutical Oral Drug Delivery Price by Application (2015-2020)
5.2 Biopharmaceutical Oral Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Biopharmaceutical Oral Drug Delivery Price Forecast by Application (2021-2026)

6 North America
6.1 North America Biopharmaceutical Oral Drug Delivery by Country
6.1.1 North America Biopharmaceutical Oral Drug Delivery Sales by Country
6.1.2 North America Biopharmaceutical Oral Drug Delivery Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Type
6.3 North America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Application

7 Europe
7.1 Europe Biopharmaceutical Oral Drug Delivery by Country
7.1.1 Europe Biopharmaceutical Oral Drug Delivery Sales by Country
7.1.2 Europe Biopharmaceutical Oral Drug Delivery Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Type
7.3 Europe Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Biopharmaceutical Oral Drug Delivery by Region
8.1.1 Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Region
8.1.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Type
8.3 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Application

9 Latin America
9.1 Latin America Biopharmaceutical Oral Drug Delivery by Country
9.1.1 Latin America Biopharmaceutical Oral Drug Delivery Sales by Country
9.1.2 Latin America Biopharmaceutical Oral Drug Delivery Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Type
9.3 Central & South America Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery by Country
10.1.1 Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country
10.1.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Type
10.3 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Biopharmaceutical Oral Drug Delivery Products Offered
11.1.5 AbbVie Related Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description and Business Overview
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Biopharmaceutical Oral Drug Delivery Products Offered
11.2.5 Amgen Related Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Description and Business Overview
11.3.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Catalent Biopharmaceutical Oral Drug Delivery Products Offered
11.3.5 Catalent Related Developments
11.4 Kemwell Bipharma.
11.4.1 Kemwell Bipharma. Corporation Information
11.4.2 Kemwell Bipharma. Description and Business Overview
11.4.3 Kemwell Bipharma. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kemwell Bipharma. Biopharmaceutical Oral Drug Delivery Products Offered
11.4.5 Kemwell Bipharma. Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Biopharmaceutical Oral Drug Delivery Products Offered
11.5.5 Pfizer Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Biopharmaceutical Oral Drug Delivery Products Offered
11.6.5 Novartis Related Developments
11.7 Biocon
11.7.1 Biocon Corporation Information
11.7.2 Biocon Description and Business Overview
11.7.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biocon Biopharmaceutical Oral Drug Delivery Products Offered
11.7.5 Biocon Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Biopharmaceutical Oral Drug Delivery Products Offered
11.8.5 Sanofi Related Developments
11.9 F. Hoffman-La Roche
11.9.1 F. Hoffman-La Roche Corporation Information
11.9.2 F. Hoffman-La Roche Description and Business Overview
11.9.3 F. Hoffman-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Products Offered
11.9.5 F. Hoffman-La Roche Related Developments
11.10 Novo Nordisk
11.10.1 Novo Nordisk Corporation Information
11.10.2 Novo Nordisk Description and Business Overview
11.10.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novo Nordisk Biopharmaceutical Oral Drug Delivery Products Offered
11.10.5 Novo Nordisk Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Biopharmaceutical Oral Drug Delivery Products Offered
11.1.5 AbbVie Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biopharmaceutical Oral Drug Delivery Market Estimates and Projections by Region
12.1.1 Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Regions 2021-2026
12.1.2 Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Regions 2021-2026
12.2 North America Biopharmaceutical Oral Drug Delivery Market Size Forecast (2021-2026)
12.2.1 North America: Biopharmaceutical Oral Drug Delivery Sales Forecast (2021-2026)
12.2.2 North America: Biopharmaceutical Oral Drug Delivery Revenue Forecast (2021-2026)
12.2.3 North America: Biopharmaceutical Oral Drug Delivery Market Size Forecast by Country (2021-2026)
12.3 Europe Biopharmaceutical Oral Drug Delivery Market Size Forecast (2021-2026)
12.3.1 Europe: Biopharmaceutical Oral Drug Delivery Sales Forecast (2021-2026)
12.3.2 Europe: Biopharmaceutical Oral Drug Delivery Revenue Forecast (2021-2026)
12.3.3 Europe: Biopharmaceutical Oral Drug Delivery Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biopharmaceutical Oral Drug Delivery Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biopharmaceutical Oral Drug Delivery Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biopharmaceutical Oral Drug Delivery Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biopharmaceutical Oral Drug Delivery Market Size Forecast by Region (2021-2026)
12.5 Latin America Biopharmaceutical Oral Drug Delivery Market Size Forecast (2021-2026)
12.5.1 Latin America: Biopharmaceutical Oral Drug Delivery Sales Forecast (2021-2026)
12.5.2 Latin America: Biopharmaceutical Oral Drug Delivery Revenue Forecast (2021-2026)
12.5.3 Latin America: Biopharmaceutical Oral Drug Delivery Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biopharmaceutical Oral Drug Delivery Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biopharmaceutical Oral Drug Delivery Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biopharmaceutical Oral Drug Delivery Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biopharmaceutical Oral Drug Delivery Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biopharmaceutical Oral Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Biopharmaceutical Oral Drug Delivery Market Segments
Table 2. Ranking of Global Top Biopharmaceutical Oral Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Normally Protein (Antibodies)
Table 5. Major Manufacturers of Nucleic Acids (DNA, RNA Or Oligonucleotides)
Table 6. Global Biopharmaceutical Oral Drug Delivery Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Biopharmaceutical Oral Drug Delivery Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Biopharmaceutical Oral Drug Delivery Sales by Regions 2015-2020 (K MT)
Table 9. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Regions (2015-2020)
Table 10. Global Biopharmaceutical Oral Drug Delivery Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Biopharmaceutical Oral Drug Delivery Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Biopharmaceutical Oral Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 13. Global Biopharmaceutical Oral Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Biopharmaceutical Oral Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Oral Drug Delivery as of 2019)
Table 15. Biopharmaceutical Oral Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Biopharmaceutical Oral Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Biopharmaceutical Oral Drug Delivery Price (2015-2020) (USD/MT)
Table 18. Biopharmaceutical Oral Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Biopharmaceutical Oral Drug Delivery Product Type
Table 20. Date of International Manufacturers Enter into Biopharmaceutical Oral Drug Delivery Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 23. Global Biopharmaceutical Oral Drug Delivery Sales Share by Type (2015-2020)
Table 24. Global Biopharmaceutical Oral Drug Delivery Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Biopharmaceutical Oral Drug Delivery Revenue Share by Type (2015-2020)
Table 26. Biopharmaceutical Oral Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 28. Global Biopharmaceutical Oral Drug Delivery Sales Share by Application (2015-2020)
Table 29. North America Biopharmaceutical Oral Drug Delivery Sales by Country (2015-2020) (K MT)
Table 30. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2015-2020)
Table 31. North America Biopharmaceutical Oral Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2015-2020)
Table 33. North America Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 34. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Table 35. North America Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 36. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Table 37. Europe Biopharmaceutical Oral Drug Delivery Sales by Country (2015-2020) (K MT)
Table 38. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2015-2020)
Table 39. Europe Biopharmaceutical Oral Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2015-2020)
Table 41. Europe Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 42. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Table 43. Europe Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 44. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Table 53. Latin America Biopharmaceutical Oral Drug Delivery Sales by Country (2015-2020) (K MT)
Table 54. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Biopharmaceutical Oral Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2015-2020)
Table 57. Latin America Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 58. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Table 59. Latin America Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 60. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Table 69. AbbVie Corporation Information
Table 70. AbbVie Description and Major Businesses
Table 71. AbbVie Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. AbbVie Product
Table 73. AbbVie Recent Development
Table 74. Amgen Corporation Information
Table 75. Amgen Description and Major Businesses
Table 76. Amgen Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Amgen Product
Table 78. Amgen Recent Development
Table 79. Catalent Corporation Information
Table 80. Catalent Description and Major Businesses
Table 81. Catalent Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Catalent Product
Table 83. Catalent Recent Development
Table 84. Kemwell Bipharma. Corporation Information
Table 85. Kemwell Bipharma. Description and Major Businesses
Table 86. Kemwell Bipharma. Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Kemwell Bipharma. Product
Table 88. Kemwell Bipharma. Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Major Businesses
Table 96. Novartis Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Biocon Corporation Information
Table 100. Biocon Description and Major Businesses
Table 101. Biocon Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Biocon Product
Table 103. Biocon Recent Development
Table 104. Sanofi Corporation Information
Table 105. Sanofi Description and Major Businesses
Table 106. Sanofi Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Sanofi Product
Table 108. Sanofi Recent Development
Table 109. F. Hoffman-La Roche Corporation Information
Table 110. F. Hoffman-La Roche Description and Major Businesses
Table 111. F. Hoffman-La Roche Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. F. Hoffman-La Roche Product
Table 113. F. Hoffman-La Roche Recent Development
Table 114. Novo Nordisk Corporation Information
Table 115. Novo Nordisk Description and Major Businesses
Table 116. Novo Nordisk Biopharmaceutical Oral Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Novo Nordisk Product
Table 118. Novo Nordisk Recent Development
Table 119. Global Biopharmaceutical Oral Drug Delivery Sales Forecast by Regions (2021-2026) (K MT)
Table 120. Global Biopharmaceutical Oral Drug Delivery Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Biopharmaceutical Oral Drug Delivery Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2021-2026) (K MT)
Table 124. North America: Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2021-2026) (K MT)
Table 126. Europe: Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Biopharmaceutical Oral Drug Delivery Sales Forecast by Region (2021-2026) (K MT)
Table 128. Asia Pacific: Biopharmaceutical Oral Drug Delivery Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2021-2026) (K MT)
Table 130. Latin America: Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Biopharmaceutical Oral Drug Delivery Sales Forecast by Country (2021-2026) (K MT)
Table 132. Middle East and Africa: Biopharmaceutical Oral Drug Delivery Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Biopharmaceutical Oral Drug Delivery Players
Table 137. Biopharmaceutical Oral Drug Delivery Customers List
Table 138. Biopharmaceutical Oral Drug Delivery Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical Oral Drug Delivery Product Picture
Figure 2. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type in 2020 & 2026
Figure 3. Normally Protein (Antibodies) Product Picture
Figure 4. Nucleic Acids (DNA, RNA Or Oligonucleotides) Product Picture
Figure 5. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Specialty Pharmacy
Figure 9. Biopharmaceutical Oral Drug Delivery Report Years Considered
Figure 10. Global Biopharmaceutical Oral Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 11. Global Biopharmaceutical Oral Drug Delivery Sales 2015-2026 (K MT)
Figure 12. Global Biopharmaceutical Oral Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region (2015-2020)
Figure 14. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Region in 2019
Figure 15. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 16. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region in 2019
Figure 17. Global Biopharmaceutical Oral Drug Delivery Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical Oral Drug Delivery Revenue in 2019
Figure 19. Biopharmaceutical Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type (2015-2020)
Figure 21. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Type in 2019
Figure 22. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type (2015-2020)
Figure 23. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Type in 2019
Figure 24. Global Biopharmaceutical Oral Drug Delivery Market Share by Price Range (2015-2020)
Figure 25. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application (2015-2020)
Figure 26. Global Biopharmaceutical Oral Drug Delivery Sales Market Share by Application in 2019
Figure 27. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application (2015-2020)
Figure 28. Global Biopharmaceutical Oral Drug Delivery Revenue Market Share by Application in 2019
Figure 29. North America Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2019
Figure 32. North America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2019
Figure 33. U.S. Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Biopharmaceutical Oral Drug Delivery Market Share by Type in 2019
Figure 38. North America Biopharmaceutical Oral Drug Delivery Market Share by Application in 2019
Figure 39. Europe Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2019
Figure 42. Europe Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2019
Figure 43. Germany Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Biopharmaceutical Oral Drug Delivery Market Share by Type in 2019
Figure 54. Europe Biopharmaceutical Oral Drug Delivery Market Share by Application in 2019
Figure 55. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Market Share by Region in 2019
Figure 58. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Market Share by Region in 2019
Figure 59. China Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Biopharmaceutical Oral Drug Delivery Market Share by Type in 2019
Figure 82. Asia Pacific Biopharmaceutical Oral Drug Delivery Market Share by Application in 2019
Figure 83. Latin America Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2019
Figure 86. Latin America Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2019
Figure 87. Mexico Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Biopharmaceutical Oral Drug Delivery Market Share by Type in 2019
Figure 94. Latin America Biopharmaceutical Oral Drug Delivery Market Share by Application in 2019
Figure 95. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Market Share by Country in 2019
Figure 99. Turkey Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Biopharmaceutical Oral Drug Delivery Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Biopharmaceutical Oral Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Share by Type in 2019
Figure 106. Middle East and Africa Biopharmaceutical Oral Drug Delivery Market Share by Application in 2019
Figure 107. North America Biopharmaceutical Oral Drug Delivery Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Biopharmaceutical Oral Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Biopharmaceutical Oral Drug Delivery Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Biopharmaceutical Oral Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Biopharmaceutical Oral Drug Delivery Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Biopharmaceutical Oral Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Biopharmaceutical Oral Drug Delivery Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Biopharmaceutical Oral Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Biopharmaceutical Oral Drug Delivery Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Biopharmaceutical Oral Drug Delivery Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed


【掲載企業】

AbbVie、Amgen、Catalent、Kemwell Bipharma.、Pfizer、Novartis、Biocon、Sanofi、F. Hoffman-La Roche、Novo Nordisk

★調査レポート[世界のバイオ医薬品経口ドラッグデリバリー市場インサイト及び予測(~2026年)] (コード:QYR20NV03256)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバイオ医薬品経口ドラッグデリバリー市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆